Lexeo Therapeutics, Inc. (LXEO) revealed Loss for its first quarter that increased from the same period last year and missed the Street estimates.
The company's bottom line totaled -$32.66 million, or -$0.99 per share. This compares with -$21.68 million, or -$0.77 per share, last year.
Analysts on average had expected the company to earn -$0.77 per share. Analysts' estimates typically exclude special items.
Lexeo Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$32.66 Mln. vs. -$21.68 Mln. last year.
-EPS: -$0.99 vs. -$0.77 last year.
For comments and feedback: editorial@rttnews.com